QCompass

With two COVID-19 vaccines close to getting EUA from the U.S. Food and Drug Administration, RedSail Technologies continues to update CDC discussions about distribution across the country. This week we talk to RedSail Technologies' Ed Vess, R.Ph., David Pope, PharmD, from OnmiSYS, and ASCP's Chad Worz, PharmD, and Arnie Clayman, PD, about the latest details.

Two pharmaceutical companies are on the cusp of asking for Emergency Use Authorization from the FDA for distribution of a COVID-19 vaccination. Get the latest on Operation Warp Speed with our guests Ed Vess and David Pope on this week's QCompass.

QS/1 is excited to share the news that a new sales representative will now serve our customers in the western region. Jerry Grannis has 22 years of experience with Rx30 and a deep knowledge of the area’s independent pharmacy landscape.

Reach him via email at [email protected] or via mobile phone at 909.732.1301.

In our weekly update on Operation Warp Speed from the CDC, RedSail Technologies' Ed Vess, R.Ph., and David Pope, Pharm.D., chief innovation officer for OmniSYS, tell us about how fields from pharmacies will be reported and more on federal partnerships.

Busy pharmacists rely on NRx to handle everything a day brings. It’s a complete solution built with decades of experience in the tools and integrations community pharmacists need. QS/1's Brian Sullivan talks about its streamlined workflow, modern health tools, flexible patient service, and how pharmacies can make sure they are getting all of the performance available.Visit www.qs1.com/nrx for more details.

Ed Vess, R.Ph, QS/1®director of professional pharmacy affairs and OmniSYS® chief innovation officer David Pope, Pharm.D., discuss registering as a mass immunizer vs. a pharmacy immunizer and an update on allocation once a COVID-19 vaccine is approved in this week's update.

Pharmacies and LTC operations are learning the reimbursement fees that will be paid when administering COVID-19 vaccines. Ed Vess, R.Ph., director of pharmacy professional affairs for RedSail Technologies and David Pope, Pharm. D., chief innovation officer for OmniSYS® give us the fourth update from the CDC on a COVID-19 vaccination.

Ed Vess, R.Ph., director of pharmacy professional affairs for RedSail Technologies and David Pope, Pharm.D., chief innovation officer for OmniSYS® give us the third update from the CDC on a COVID-19 vaccination that will be given out in pharmacies and long-term care operations.

Late last Friday, HHS announced a partnership with two chain pharmacies to deliver COVID-19 vaccine options to LTC facilities. It is important to note the program is not limited to these pharmacies. Independent pharmacies are still critical to the success of the program, especially in rural and medically under served areas. Our Ed Vess, R.Ph., director of professional pharmacy affairs, discusses the misinformation and confusion this announcement is causing.

The CDC continues its weekly update for pharmacies in preparation of a COVID-19 vaccination. Our own Ed Vess, director of Pharmacy Professional Affairs, and OmniSYS® Chief Innovation Officer David Pope sit down with us on the latest information from this update.